Sebastian Jäger

The paper describes a modular method to generate PROxAb Shuttles by conjugating PROTAC-binding VHHs to antibodies, enabling targeted protein degradation and bispecific antibody creation.

This paper introduces a platform for creating tumor-targeting antibody-PROTAC conjugates that enhances bioavailability and specificity without modifying PROTACs or antibodies.